Basic Information
Basic information for MIR9-3HG-213-30aa
Peptide Name MIR9-3HG-213-30aa
Genome Position chr15:89389383-89389472[+]
Species Human
Peptide Sequence MAETAGPTLHSHQHLSPQPCLLFCSWDLHI
Peptide Length 30
Unique No (MIR9-3HG-201-30aa,MIR9-3HG-202-30aa,MIR9-3HG-203-30aa,MIR9-3HG-204-30aa,MIR9-3HG-205-30aa,MIR9-3HG-206-30aa,MIR9-3HG-207-30aa,MIR9-3HG-208-30aa,MIR9-3HG-210-30aa,MIR9-3HG-211-30aa,MIR9-3HG-212-30aa,MIR9-3HG-214-30aa,MIR9-3HG-215-30aa,MIR9-3HG-216-30aa,MIR9-3HG-217-30aa,MIR9-3HG-218-30aa,MIR9-3HG-219-30aa,MIR9-3HG-220-30aa,MIR9-3HG-221-30aa,MIR9-3HG-222-30aa,MIR9-3HG-223-30aa,MIR9-3HG-224-30aa,MIR9-3HG-225-30aa,MIR9-3HG-226-30aa,MIR9-3HG-227-30aa,MIR9-3HG-228-30aa,MIR9-3HG-229-30aa,MIR9-3HG-230-30aa,MIR9-3HG-231-30aa,MIR9-3HG-233-30aa,MIR9-3HG-234-30aa,MIR9-3HG-235-30aa,MIR9-3HG-236-30aa,MIR9-3HG-237-30aa,MIR9-3HG-238-30aa,MIR9-3HG-239-30aa,MIR9-3HG-240-30aa,MIR9-3HG-241-30aa,MIR9-3HG-242-30aa,MIR9-3HG-243-30aa,MIR9-3HG-244-30aa,MIR9-3HG-245-30aa,MIR9-3HG-246-30aa,MIR9-3HG-247-30aa,MIR9-3HG-248-30aa,MIR9-3HG-249-30aa,MIR9-3HG-250-30aa,MIR9-3HG-251-30aa,MIR9-3HG-252-30aa,MIR9-3HG-253-30aa)
Grand Average of Hydropathicity 0.0033
Relative Molecular Mass 3893.36
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654171;MIR9-3HG-213
Transcript Length 4350
Coding Ability 0.4352
DNA Sequence Corresponding to Peptide ATGGCCGAGACAGCAGGTCCCACCCTGCACAGCCACCAGCATCTCTCCCCTCAGCCCTGTCTCCTCTTCTGCAGTTGGGATCTGCACATT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :